All terms in GO
| Label | Id | Description |
|---|---|---|
| 2-deoxystreptamine biosynthetic process | GO_1901744 |
The chemical reactions and pathways resulting in the formation of 2-deoxystreptamine.
|
| prephenate(2-) metabolic process | GO_1901745 |
The chemical reactions and pathways involving prephenate(2-).
|
| prephenate(2-) catabolic process | GO_1901746 |
The chemical reactions and pathways resulting in the breakdown of prephenate(2-).
|
| beta1-adrenergic receptor activity | GO_0004940 |
Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta1-adrenergic receptors.
|
| beta-adrenergic receptor activity | GO_0004939 |
Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta-adrenergic receptors; the activity involves transmitting the signal to the Gs alpha subunit of a heterotrimeric G protein.
|
| prephenate(2-) biosynthetic process | GO_1901747 |
The chemical reactions and pathways resulting in the formation of prephenate(2-).
|
| beta2-adrenergic receptor activity | GO_0004941 |
Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta2-adrenergic receptors.
|
| leukotriene D4 metabolic process | GO_1901748 |
The chemical reactions and pathways involving leukotriene D4.
|
| GO_0004942 | GO_0004942 | |
| leukotriene D4 catabolic process | GO_1901749 |
The chemical reactions and pathways resulting in the breakdown of leukotriene D4.
|
| leukotriene catabolic process | GO_0036100 |
The chemical reactions and pathways resulting in the breakdown of a leukotriene, a pharmacologically active substance derived from a polyunsaturated fatty acid, such as arachidonic acid.
|
| GO_0004943 | GO_0004943 | |
| GO_0004944 | GO_0004944 | |
| angiotensin type II receptor activity | GO_0004945 |
An angiotensin receptor activity that acts via Gi protein coupling and cGMP (NO) generation, and may also act via additional signaling mechanisms.
|
| angiotensin receptor activity | GO_0001595 |
Combining with angiotensin to initiate a change in cell activity.
|
| bombesin receptor activity | GO_0004946 |
Combining with bombesin to initiate a change in cell activity.
|
| neuropeptide receptor activity | GO_0008188 |
Combining with a neuropeptide to initiate a change in cell activity.
|
| bradykinin receptor activity | GO_0004947 |
Combining with bradykinin to initiate a change in cell activity.
|
| calcitonin receptor activity | GO_0004948 |
Combining with calcitonin and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
|
| cannabinoid receptor activity | GO_0004949 |
Combining with a cannabinoid to initiate a change in cell activity. Cannabinoids are a class of diverse chemical compounds that include the endocannabinoids and the phytocannabinoids.
|